Freedom from serious drug harms.
To help people and institutions, regardless of their status or beliefs, to minimise serious harms from legal and illicit drugs.
Penington Institute champions an open, rational, and compassionate approach to building and sharing knowledge to reduce drug-related harm.
We push for an effective regulatory framework for cannabis defined by public health goals, with priority placed on targeted prevention, education, and treatment.
Penington Institute produces Australia’s Annual Overdose Report to demonstrate the nature of the overdose crisis and to support change to reduce drug-induced deaths.
Penington Institute statement on the NSW Government’s response to recommendations from the NSW Drug Summit. Attributable to Penington Institute Acting CEO and Director of Research, Dr Jake Dizard: “The NSW Government has opted not to embrace key recommendations from community members and experts designed to minimise harm and make the
Some leading Australian medical bodies are failing to take account of wider public health considerations in debates about medicinal cannabis access and reform. In response to a Federal Government-commissioned review into medicinal cannabis, groups including the Australian Medical Association have called for an immediate halt to the prescribing and dispensing of
The Therapeutic Goods Administration is being urged to maintain a balanced and evidence-based approach to medicinal cannabis access – or risk driving people to the unregulated illicit market. Amid rising concerns about patient safety in the medicinal cannabis sector, the TGA is reviewing medicinal cannabis regulations to ensure appropriate regulatory oversight
Penington Institute statement on the NSW Government’s response to recommendations from the NSW Drug Summit. Attributable to Penington Institute Acting CEO and Director of Research, Dr Jake Dizard: “The NSW Government has opted not to embrace key recommendations from community members and experts designed to minimise harm and make the
Some leading Australian medical bodies are failing to take account of wider public health considerations in debates about medicinal cannabis access and reform. In response to a Federal Government-commissioned review into medicinal cannabis, groups including the Australian Medical Association have called for an immediate halt to the prescribing and dispensing of
The Therapeutic Goods Administration is being urged to maintain a balanced and evidence-based approach to medicinal cannabis access – or risk driving people to the unregulated illicit market. Amid rising concerns about patient safety in the medicinal cannabis sector, the TGA is reviewing medicinal cannabis regulations to ensure appropriate regulatory oversight
Penington Institute convenes the world’s largest annual campaign to end the overdose crisis. International Overdose Awareness Day falls on August 31 each year.
